Inosine Triphosphate Pyrophosphohydrolase (ITPA) polymorphic sequence variants in adult hematological malignancy patients and possible association with mitochondrial DNA defects

Journal of Hematology and Oncology

Volumn 6, Issue 1, 2013, Pages

  Zamzami, Mazin A ^a   Duley, John A ^b,c,d   Price, Gareth R ^c,d   Venter, Deon J ^b,c,d   Yarham, John W ^e   Taylor, Robert W ^e   Catley, Laurence P ^b,c   Florin, Timothy Hj ^b,c   Marinaki, Anthony M ^f   Bowling, Francis ^b,c  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^d MATER HOSPITAL   (Australia)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Haematological malignancy; ITPA; Microarray; Mitochondria; N call

Indexed keywords

INORGANIC PYROPHOSPHATASE; INOSINE TRIPHOSPHATE; INOSINE TRIPHOSPHATE PYROPHOSPHOHYDROLASE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW; DNA EXTRACTION; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HEMATOLOGIC MALIGNANCY; HUMAN; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MITOCHONDRIAL DNA DISORDER; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; PILOT STUDY; RISK FACTOR; SYNDROME; WILD TYPE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; DNA, MITOCHONDRIAL; HEMATOLOGIC NEOPLASMS; HUMANS; MICE; MICE, KNOCKOUT; MICROARRAY ANALYSIS; MIDDLE AGED; POLYMORPHISM, GENETIC; PYROPHOSPHATASES;

EID: 84875391007     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-6-24     Document Type: Article

References (49)

1. Pharmacogenetic significance of inosine triphosphatase. Bierau J, Lindhout M, Bakker JA, Pharmacogenomics 2007 8 9 1221 1228 10.2217/14622416.8.9. 1221 17924837 (Pubitemid 47578231)
2. Cloning, expression, and characterization of a human InosineTriphosphate pyrophosphatase encoded by the ITPA gene. Lin S, McLennan AG, Ying K, Wang Z, Gu S, Jin H, Wu C, Liu W, Yuan Y, Tang R, J Biol Chem 2001 276 22 18695 18701 10.1074/jbc.M011084200 11278832
3. Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency. Sumi S, Marinaki AM, Arenas M, Fairbanks L, Shobowale-Bakre M, Rees DC, Thein SL, Ansari A, Sanderson J, De Abreu RA, Hum Genet 2002 111 4-5 360 367 12384777 (Pubitemid 36075062)
4. House cleaning, a part of good housekeeping. Galperin MY, Moroz OV, Wilson KS, Murzin AG, Mol Microbiol 2006 59 1 5 19 10.1111/j.1365-2958.2005. 04950.x 16359314
5. Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase). Marinaki AM, Ansari A, Duley JA, Arenas M, Sumi S, Lewis CM, Shobowale-Bakre el M, Escuredo E, Fairbanks LD, Sanderson JD, Pharmacogenetics 2004 14 3 181 187 10.1097/00008571-200403000-00006 15167706 (Pubitemid 38373112)
6. ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C. Fellay J, Thompson AJ, Dongliang G, Gumbs CE, Urban T, Shianna KV, Little LD, Qiu P, Bertelsen AH, Watson M, Nature 2010 464 405 408 10.1038/nature08825 20173735
7. ITPase-deficient mice show growth retardation and die before weaning. Behmanesh M, Sakumi K, Abolhassani N, Toyokuni S, Oka S, Ohnishi NY, Tsuchimoto D, Nakabeppu Y, Cell Death Differ 2009 16 1315 1322 10.1038/cdd.2009.53 19498443
8. NUDT16 and ITPA play a dual protective role in maintaining chromosome stability and cell growth by eliminating dIDP/IDP and dITP/ITP from nucleotide pools in mammals. Abolhassani N, Iyama T, Tsuchimoto D, Sakumi K, Ohno M, Behmanesh M, Nakabeppu Y, Nucleic Acids Res 2010 38 9 2891 2903 10.1093/nar/gkp1250 20081199
9. A Japanese case with inosine triphosphate pyrophosphohydrolase deficiency attributable to an enzymatic defect in white blood cells. Sumi S, Ueta A, Maeda T, Ito T, Ohkubo Y, Togari H, J Inherit Metab Dis 2004 27 2 277 278 15243983 (Pubitemid 38756344)
10. Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies. Poppe B, Vandesompele J, Schoch C, Lindvall C, Mrozek K, Bloomfield CD, Beverloo HB, Michaux L, Dastugue N, Herens C, Blood 2004 103 1 229 235 10.1182/blood-2003-06-2163 12946992 (Pubitemid 38029943)
11. Pivotal role of inosine triphosphate pyrophosphatase in maintaining genome stability and the prevention of apoptosis in human cells. Menezes MR, Waisertreiger IS, Lopez-Bertoni H, Luo X, Pavlov YI, PLoS One 2012 7 2 27
12. The ITPA c.94C>A and g.IVS2+21A>C sequence variants contribute to missplicing of the ITPA gene. Arenas M, Duley J, Sumi S, Sanderson J, Marinaki A, Biochim Biophys Acta 2007 1772 96 102 10.1016/j.bbadis.2006.10.006 17113761 (Pubitemid 44960729)
13. Distribution of ITPA P32T alleles in multiple world populations. Marsh S, King CR, Ahluwalia R, McLeod HL, J Hum Genet 2004 49 579 581 10.1007/s10038-004-0183-y 15322947 (Pubitemid 39506541)
14. Mitochondrial DNA mutations in human disease. Taylor RW, Turnbull DM, Nat Rev Genet 2005 6 5 389 402 15861210 (Pubitemid 40577182)
15. Nucleotides function as endogenous chemical sensors for oxidative stress signaling. Ihara H, Sawa T, Nakabeppu Y, Akaike T, J Clin Biochem Nutr 2011 48 1 33 39 21297909
16. Oxidation in the nucleotide pool, the DNA damage response and cellular senescence: Defective bricks build a defective house. Rai P, Mutat Res 2010 703 1 71 81 10.1016/j.mrgentox.2010.07.010 20673809
17. Mitochondrial DNA mutations and human disease. Tuppen HAL, Blakely EL, Turnbull DM, Taylor RW, Biochim Biophys Acta 2010 1797 113 128 19761752
18. Mitochondrial defects in cancer. Carew JS, Huang P, Molecular Cancer 2002 1 9 1 12
19. ReseqChip: Automated integration of multiple local context probe data from the MitoChip array in mitochondrial DNA sequence assembly. Thieme M, Lottaz C, Niederstätter H, Parson W, Spang R, Oefner PJ, BMC Bioinforma 2009 10 440 1 10
20. Hartwell L, Hood L, Goldberg ML, Reynolds AE, Silver LM, Veres RC, Genetics: from genes to genomes Boston: McGraw-Hill Higher Education 2 2004
21. Mitochondrial transfection for studying organellar DNA repair, genome maintenance and aging. Mileshina D, Ibrahim N, Boesch P, Lightowlers RN, Dietrich A, Weber-Lotfi F, Mech Ageing Dev 2011 132 412 423 10.1016/j.mad.2011. 05.002 21645537
22. DNA damage and base excision repair inMitochondria and their role in aging. Gredilla R, Journal of Aging Research 2011 2011 1 9
23. Mitochondrial threshold effects. Rossignol R, Faustin B, Rocher C, Malgat M, Mazat JP, Letellier T, Biochem J 2003 370 Pt 3 751 762 12467494 (Pubitemid 36399067)
24. Deoxyuridine accumulation in urine in thymidine phosphorylase deficiency (MNGIE). Fairbanks LD, Marinaki AM, Carrey EA, Hammans SR, Duley JA, J Inherit Metab Dis 2002 25 603 604 10.1023/A:1022007827133 12638947 (Pubitemid 36266999)
25. Alteration of nucleotide metabolism: a new mechanism for mitochondrial disorders. Marti R, Nishigaki Y, Vila MR, Hirano M, Clin Chem Lab Med 2003 41 7 845 851 12940507 (Pubitemid 37010174)
26. Mitochondria and cancer. Costello L, Singh K, Mitochondria in Hematology Springer: New York, Costello L, Singh K, 2009 163 185
27. Chromosomal abnormalities in cancer. Fröhling S, Döhner H, N Engl J Med 2008 359 7 722 734 10.1056/NEJMra0803109 18703475
28. Chromosome abnormalities and cancer cytogenetics. Lobo I, Nature Education 2008 1 1 http://www.nature.com/scitable/topicpage/chromosome- abnormalities-and-cancer-cytogenetics-879 (accessed March 19, 2013)
29. Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. Voso MT, Fabiani E, D'Alo F, Guidi F, Di Ruscio A, Sica S, Pagano L, Greco M, Hohaus S, Leone G, Ann Oncol 2007 18 1523 1528 10.1093/annonc/mdm191 17761709 (Pubitemid 47365486)
30. Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes. Fabiani E, D'Alo F, Scardocci A, Greco M, Di Ruscio A, Criscuolo M, Fianchi L, Pagano L, Hohaus S, Leone G, Leuk Res 2009 33 1068 1071 10.1016/j.leukres.2008.10.012 19027952
31. The Human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection. Maitra A, Cohen Y, Gillespie SE, Mambo E, Fukushima N, Hoque MO, Shah N, Goggins M, Califano J, Sidransky D, Genome Res 2004 14 5 812 819 10.1101/gr.2228504 15123581 (Pubitemid 38660497)
32. An oligonucleotide microarray for high-throughput sequencing of the mitochondrial genome. Zhou S, Kassauei K, Cutler DJ, Kennedy GC, Sidransky D, Maitra A, Califano J, J Mol Diagn 2006 8 4 476 482 10.2353/jmoldx.2006.060008 16931588 (Pubitemid 44377930)
33. HaploGrep: a fast and reliable algorithm for automatic classification of mitochondrial DNA haplogroups. Kloss-Brandstaetter A, Pacher D, Schoenherr S, Weissensteiner H, Binna R, Specht G, Kronenberg F, Hum Mutat 2011 32 1 25 32 10.1002/humu.21382 20960467
34. Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. van Oven M, Kayser M, Hum Mutat 2009 30 2 386 394 10.1002/humu.20921
35. High-throughput detection of mutations responsible for childhood hearing loss using resequencing microarrays. Kothiyal P, Cox S, Ebert J, Husami A, Kenna MA, Greinwald JH, Aronow BJ, Rehm HL, BMC Biotechnol 2010 10 10 PMID20146813
36. Genetic basis of hemolytic anemia caused by pyrimidine 5′ nucleotidase deficiency. Marinaki AM, Escuredo E, Duley JA, Simmonds HA, Amici A, Naponelli V, Magni G, Seip M, Ben-Bassat I, Harley EH, Blood 2001 97 11 3327 3332 10.1182/blood.V97.11.3327 11369620
37. Human inosine triphosphatase: catalytic properties and population studies. Holmes SL, Turner BM, Hirschhorn K, Clin Chim Acta 1979 97 2-3 143 153 487601 (Pubitemid 10241614)
38. 6-Thioguanine damages mitochondrial DNA and causes mitochondrial dysfunction in human cells. Daehn I, Brem R, Barkauskaite E, Karran P, FEBS Lett 2011 585 24 3941 3946 10.1016/j.febslet.2011.10.040 22062154
39. Mitochondrial DNA in human malignancy. Penta JS, Johnson FM, Wachsman JT, Copeland WC, Mutat Res 2001 488 119 133 10.1016/S1383-5742(01)00053-9 11344040 (Pubitemid 32436427)
40. Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes. Wulferta M, Kuppera AC, Tappricha C, Bottomley SS, Bowenc D, Germinga U, Haasa R, Gattermanna N, Exp Hematol 2008 36 577 586 10.1016/j.exphem.2008. 01.004 18439489 (Pubitemid 351551472)
41. Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications. Carew JS, Zhou Y, Albitar M, Carew JD, Keating MJ, Huang P, Leukemia 2003 17 1437 1447 10.1038/sj.leu.2403043 12886229 (Pubitemid 36986944)
42. Somatic mitochondrial DNA mutations in adult-onset leukaemia. He L, Luo L, Proctor SJ, Middleton PG, Blakely EL, Taylor RW, Turnbull DM, Leukemia 2003 17 2487 2491 10.1038/sj.leu.2403146 14523470 (Pubitemid 38072588)
43. Efficient random mutagenesis method with adjustable mutation frequency by use of PCR and dITP. Spee JH, Vos WM, Kuipers OP, Nucleic Acids Res 1993 21 3 777 778 10.1093/nar/21.3.777 8441702 (Pubitemid 23155591)
44. Mutation induced by deoxyxanthosine in codon 12 of a synthetic c-haras gene. Kamiya H, Shimizu M, Suzuki M, Inoue H, Ohtsuka E, Nucleos Nucleot Nucleic Acids 1992 11 2-4 247 260
45. Mutagenic potentials of damaged nucleic acids produced by reactive oxygen/nitrogen species: approaches using synthetic oligonucleotides and nucleotides: survey and summary. Kamiya H, Nucleic Acids Res 2003 31 2 517 531 10.1093/nar/gkg137 12527759 (Pubitemid 36175941)
46. Xanthine, xanthosine and its nucleotides: solution structures of neutral and ionic forms, and relevance to substrate properties in various enzyme systems and metabolic pathways. Kulikowska E, Kierdaszuk B, Shugar D, Acta Biochimica Polonica 2004 51 2 493 531 15218545 (Pubitemid 38969310)
47. Genetic causes of mitochondrial DNA depletion in humans. Rötig A, Poulton J, Biochim Biophys Acta 2009 1792 1103 1108 10.1016/j.bbadis.2009.06.009 19596444
48. Insights into N-calls of mitochondrial DNA sequencing using MitoChip v2.0. Zamzami MA, Price GR, Taylor RW, Blakely EL, Oancea I, Bowling F, Duley JA, BMC Res Notes 2011 4 1 426 10.1186/1756-0500-4-426 22011414
49. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy. Carney DA, Westerman DA, Tam CS, Milner A, Prince HM, Kenealy M, Wolf M, Januszewicz EH, Ritchie D, Came N, Leukemia 2010 24 12 2056 2062 10.1038/leu.2010.218 20962860